welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
scientific articles
Celecoxib in a 12-Year-Old Boy with Familial Adenomatous Polyposis
source: International journal of clinical pharmacology and therapeutics
year: 2010
authors: Pérez-Segura P, Bodas A, Sereno M, Martínez-Amores B, Olivera H, Díaz S, López-Asenjo J A, Puente J, Maluenda C, Díaz-Rubio E
summary/abstract:Familial Adenomatous Polyposis (FAP) is an autosomal dominant disorder characterized by colonic polyps in early adult life. Children with this disease are at risk for colonic cancer, so prophylactic colectomy is the standard treatment to prevent this complication. Chemoprevention experience with NSAIDs in children is exceptional. This case report describes our experience with Celecoxib, a COX-2 inhibitor, in a 12-year-old boy.
organisation: Hospital Clínico San Carlosread more full text source
expertly curated content related to this topic
-
Discussing Pediatric Familial Polyposis and Colorectal Cancerhttps://youtu.be/km3FYvoOV94...
-
The Safety and Efficacy of Celecoxib in Children with Familial Adenomatous PolyposisOBJECTIVES : Celecoxib is approved as an...
-
Considerations and Complications in Patients Undergoing Ileal Pouch Anal AnastomosisTotal proctocolectomy with ileal pouch a...
-
Familial Adenomatous Polyposis: Ileo-Anal Pouch versus Ileo-Rectal AnastomosisAIM : In this study we describe the pres...
-
Prevalence and Outcome of Anemia After Restorative Proctocolectomy: A Clinical Literature ReviewPURPOSE : Iron and/or vitamin B12 defici...
-
Rectal Epithelial Apoptosis in Familial Adenomatous Polyposis Patients Treated with SulindacBACKGROUND : Sulindac regresses colorect...
-
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...Purpose: To provide recommendations on ...